Chlordiazepoxide
- Generic Name
- Chlordiazepoxide
- Brand Names
- Chlorax, Librax
- Drug Type
- Small Molecule
- Chemical Formula
- C16H14ClN3O
- CAS Number
- 58-25-3
- Unique Ingredient Identifier
- 6RZ6XEZ3CR
- Background
An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
- Indication
Chlordiazepoxide is indicated for the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.
In combination with amitriptyline, chlordiazepoxide is indicated for the treatment of moderate to severe depression. In combination with clidinium, chlordiazepoxide is indicated to control emotional and somatic factors in gastrointestinal disorders, and is used as adjunctive therapy in the treatment of peptic ulcer, irritable bowel syndrome and acute enterocolitis.
- Associated Conditions
- Alcohol Withdrawal Syndrome, Anxiety Disorders, Depression, Irritable Bowel Syndrome (IBS), Peptic Ulcer Disease, Preoperative Anxiety, Acute Enterocolitis
- Associated Therapies
- -
Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal
- First Posted Date
- 2012-04-06
- Last Posted Date
- 2020-08-17
- Lead Sponsor
- VA Salt Lake City Health Care System
- Target Recruit Count
- 26
- Registration Number
- NCT01573052
- Locations
- 🇺🇸
George E Wahlen VA Medical Center, Salt Lake City, Utah, United States
Outpatient Treatment of Alcohol Withdrawal Syndrome
- Conditions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2009-03-02
- Lead Sponsor
- Hvidovre University Hospital
- Target Recruit Count
- 165
- Registration Number
- NCT00136617
- Locations
- 🇩🇰
Alcohol Clinics at Hvidovre Hospital, Hvidovre, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.